Who has invested in DIAGENS?

No investors are named on the public record for DIAGENS yet.

DIAGENS Funding: $101M Raised, IPO (2026)

DIAGENS funding overview

DIAGENS is based in Hangzhou, China. DIAGENS has raised $101M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in March 2026. The round record for DIAGENS runs through 2026; nothing later has been disclosed.

DIAGENS at a glance

Total raised: $101M
Latest round: IPO
Latest round date: March 2026
Headquarters: Hangzhou, China

Frequently asked about DIAGENS funding

How much has DIAGENS raised?: DIAGENS has raised $101M in total disclosed funding across the rounds on record.
Who has invested in DIAGENS?: No investors are named on the public record for DIAGENS yet.
What was the latest DIAGENS funding round?: The most recent disclosed round is an IPO, announced in March 2026.
Where is DIAGENS based?: DIAGENS is based in Hangzhou, China.
When did DIAGENS last raise?: The last disclosed DIAGENS round closed in March 2026 at IPO.

Round data for DIAGENS is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Hangzhou and backer lists below.

DIAGENS Funding: $101M Raised, IPO (2026)

DIAGENS funding overview

DIAGENS at a glance

Frequently asked about DIAGENS funding

DIAGENS funding history

Companies related to DIAGENS (18)

Browse related funding lists (3)